Verrica Pharmaceuticals (VRCA) Other Gross PP&E Adjustments (2021 - 2025)
Verrica Pharmaceuticals (VRCA) has 5 years of Other Gross PP&E Adjustments data on record, last reported at -$4.1 million in Q4 2025.
- For Q4 2025, Other Gross PP&E Adjustments fell 29.74% year-over-year to -$4.1 million; the TTM value through Dec 2025 reached -$4.1 million, down 29.74%, while the annual FY2025 figure was -$4.1 million, 29.74% down from the prior year.
- Other Gross PP&E Adjustments reached -$4.1 million in Q4 2025 per VRCA's latest filing, down from $209000.0 in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $4.5 million in Q4 2022 and bottomed at -$4.1 million in Q4 2025.
- Average Other Gross PP&E Adjustments over 5 years is $821900.0, with a median of $1.5 million recorded in 2021.
- Peak YoY movement for Other Gross PP&E Adjustments: crashed 780.0% in 2024, then soared 494.25% in 2025.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at $2.1 million in 2021, then soared by 112.18% to $4.5 million in 2022, then plummeted by 107.84% to -$355000.0 in 2023, then tumbled by 780.0% to -$3.1 million in 2024, then dropped by 29.74% to -$4.1 million in 2025.
- Per Business Quant database, its latest 3 readings for Other Gross PP&E Adjustments were -$4.1 million in Q4 2025, $209000.0 in Q3 2025, and $94000.0 in Q2 2025.